Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause.

Khan, Muhammad Shahzeb; Butler, Javed; Anker, Stefan D; Filippatos, Gerasimos; Ferreira, João Pedro; Pocock, Stuart J; Januzzi, James L; Piña, Ileana L; Böhm, Michael; Ponikowski, Piotr; +6 more... Verma, Subodh; Brueckmann, Martina; Vedin, Ola; Zeller, Cordula; Zannad, Faiez; Packer, Milton; (2022) Impact of Empagliflozin in Heart Failure With Reduced Ejection Fraction in Patients With Ischemic Versus Nonischemic Cause. Journal of the American Heart Association, 12 (1). e027652-. ISSN 2047-9980 DOI: https://doi.org/10.1161/JAHA.122.027652

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1161/JAHA.122.027652

Abstract

Share

Download

Filename: Khan-etal-2023-Impact-of-empagliflozin-in-heart.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar